ANN ARBOR STAGE I GRADE 2 FOLLICULAR LYMPHOMA
Clinical trials for ANN ARBOR STAGE I GRADE 2 FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE I GRADE 2 FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE I GRADE 2 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drug boost Radiation's power against Slow-Growing lymphoma?
Disease control OngoingThis study is testing whether adding the drug rituximab to standard radiation therapy works better than radiation alone for people with early-stage, slow-growing follicular lymphoma. Rituximab is an immunotherapy drug that helps the immune system attack cancer cells. The main goa…
Matched conditions: ANN ARBOR STAGE I GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Gentler radiation zaps eye lymphoma with fewer side effects
Disease control OngoingThis study is testing whether a very low dose of radiation aimed at the eye socket can effectively control slow-growing B-cell lymphomas that involve the eye area. It aims to see if this lower dose can work as well as standard treatments while causing fewer side effects. The tria…
Matched conditions: ANN ARBOR STAGE I GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC